Article
Cytosolic Phosphoenoylpyruvate Carboxykinase Deficiency: Clinical, Biochemical, and Genetic Features of Five Non-Finnish Patients.
American journal of medical genetics. Part A - 1 Jun 2026
Bernhardt Isaac, Stabej Polona Le Quesne, Hart Claire, De Hora Mark, Hulley Sarah, Anderson Mark, Leitch Harry G, Lemonde Hugh, Ryder Bryony, Davison James
Abstract excerpt
Cytosolic phosphoenoylpyruvate carboxykinase (PEPCK-C) is an essential, rate-limiting enzyme in the gluconeogenesis pathway. PEPCK-C deficiency presents with hypoglycaemia, hyperlactataemia and hepatopathy, and was first reported in association with bi-allelic PCK1 variants in 2014. A Finnish cohort with a common homozygous variant (c.925G>A, p.(Gly309Arg)) is well-described, but few other genotypes are reported....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
